Comparing Acceptance and Commitment Therapy and Supportive Diabetes Counseling to a Waitlist Control for Treating Eating Disorders in Type 1 Diabetes

What this Trial Is About

Researchers are evaluating treatments for eating disorders in people with type 1 diabetes through a randomized controlled trial. This study compares Acceptance and Commitment Therapy ACT with Supportive Diabetes Counseling and a 6-month Waitlist Control. It aims to see if these treatments improve blood sugar control, eating disorder symptoms, diabetes management, and diabetes-related distress, while also exploring how and for whom the treatments work. Participants receive one of three options the ACT program with 12 therapy sessions tailored to type 1 diabetes eating disorders using a mix of in-person and virtual visits plus supportive text messaging Supportive Diabetes Counseling consisting of 12 sessions focused on listening, diabetes education, and goal setting or placement on a waitlist without treatment. Both active treatments are delivered over 12 to 16 weeks and include phone-based support between sessions to boost engagement. During the study, participants undergo regular assessments including continuous glucose monitoring, blood tests for HbA1c, diagnostic interviews, surveys, and tests measuring attention, heart rate, and reaction time. Evaluations occur at baseline, mid-treatment, end-of-treatment, and at 1, 3, and 6 months after treatment ends. These measures help researchers understand treatment effects on health and behavior. The total participation lasts several months with follow-up to track lasting changes and safety.

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes